CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-18 | Shah Gaurav CEO | Sale | −2,293 | $3.38 | $8K | 1,056,594 |
| 2026-08-13 | Shah Gaurav CEO | Sale | −2,837 | $3.38 | $10K | 1,058,887 |
| 2026-05-21 | Shah Gaurav CEO | Option exercise | +76,490 | $1.69 | $129K | 1,117,408 |
| 2026-05-21 | Shah Gaurav CEO | Sale | −55,684 | $3.09 | $172K | 1,061,724 |
| 2026-05-21 | Shah Gaurav CEO | Option exercise · Stock Option (Right to Buy) | −76,490 | $1.69 | $129K | 0 |
| 2026-05-19 | Shah Gaurav CEO | Sale | −2,409 | $3.01 | $7K | 1,040,918 |
| 2026-05-13 | Shah Gaurav CEO | Sale | −2,728 | $3.61 | $10K | 1,043,327 |
| 2026-02-18 | Shah Gaurav CEO | Sale | −5,990 | $3.34 | $20K | 1,046,055 |
| 2026-02-13 | Shah Gaurav CEO | Sale | −12,279 | $3.31 | $41K | 1,052,045 |
| 2026-02-11 | Shah Gaurav CEO | Grant or award | +286,028 | 1,064,324 | ||
| 2026-02-11 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +870,648 | 870,648 | ||
| 2025-11-18 | Shah Gaurav CEO | Sale | −6,276 | $2.98 | $19K | 778,296 |
| 2025-08-18 | Shah Gaurav CEO | Shares withheld for taxes | −2,234 | $3.05 | $7K | 784,572 |
| 2025-05-20 | Shah Gaurav CEO | Sale | −2,253 | $6.45 | $15K | 786,806 |
| 2025-05-16 | Shah Gaurav CEO | Sale | −3,621 | $6.53 | $24K | 789,059 |
| 2025-04-10 | Shah Gaurav CEO | Purchase | +20,000 | $5.08 | $102K | 792,680 |
| 2025-02-21 | Shah Gaurav CEO | Sale | −16,303 | $10.58 | $172K | 772,680 |
| 2025-02-11 | Shah Gaurav CEO | Grant or award | +81,655 | 788,983 | ||
| 2025-02-11 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +243,345 | 243,345 | ||
| 2024-11-21 | Shah Gaurav CEO | Sale | −11,091 | $13.05 | $145K | 707,328 |
Page 1 of 1 · 20 trades